Figure 3.

Fasting plasma glucose (FPG): change from baseline with linagliptin or placebo. Number of patients is the full analysis set (all patients with a baseline and at least one on-treatment FPG value). All studies were of 24 weeks’ duration. Mean change in FPG from baseline to week 24 was adjusted for baseline HbA_1c, FPG and previous oral antidiabetic drug treatment. Difference (linagliptin minus placebo) was highly significant for all studies (p < 0.0001). To convert glucose from milligrams per deciliter (mg/dl) to millimoles per liter (mmol/l), multiply by 0.05551.

FPG, fasting plasma glucose; SE, standard error; CI, confidence interval.